Research investigating IL-33/ST2's role in parasitic infection shows that its modulation may demonstrate a viable treatment strategy, though due to the varying nature in IL-33/ST2 signaling in the host immune response, there is a need for further research on the topic. Here, IL33 is linked to parasitic infectious disease.